SEC Form 4 research

STEMLINE THERAPEUTICS INC insider transactions

Recent insider disclosures

No matching recent records; this is not a statement about historical activity.

Officers and directors in the directory

• BUCHI J KEVIN — 19 qualifying
• BENTSUR RON — 155 qualifying
• Hoberman Kenneth — 45 qualifying
• Forman Alan S — 5 qualifying
• Rowinsky Eric K — 21 qualifying
• Bergstein Ivan — 33 qualifying
• Francomano Robert — 7 qualifying
• Gionco David — 40 qualifying
• ZUERBLIS KENNETH J — 9 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.